(Stroke. 2002;33:1301.)
© 2002 American Heart Association, Inc.
Original Contributions |
From the Stroke Program, Department of Neurology, University of Texas-Houston Medical School. Dr Felberg is now at the Department of Neurology, Ochsner Foundation Hospital, New Orleans, La.
Correspondence to Robert A. Felberg, MD, Stroke Program Director, Department of Neurology, Ochsner Foundation Hospital, 1514 Jefferson Hwy, New Orleans, LA 70118. E-mail Rfelberg{at}ochsner.org
Background and Purpose Acute-stroke patients receiving standard intravenous tissue plasminogen activator (tPA) have been noted to experience early dramatic recoveries. The prevalence, clinical characteristics, and outcome of patients experiencing dramatic recovery is not well described.
Methods We prospectively studied all patients presenting with acute middle cerebral artery (MCA) stroke syndromes and transcranial Doppler (TCD) evidence of an MCA obstruction. All patients received intravenous tPA per the National Institute of Neurological and Communicative Disorders and Stroke protocol, with serial National Institutes of Health Stroke Scale (NIHSS) scores and continuous TCD monitoring. Dramatic recovery was defined as an improvement of
10 NIHSS points or a decrease to an NIHSS score of
3 by the end of infusion. Outcome at the end of infusion, at 24 hours, and at long-term follow-up were obtained. The timing and pattern of deficit recovery during dramatic recovery was also studied.
Results Dramatic recovery occurred in 22% of all patients. Compared with patients who did not experience dramatic recovery, those patients who did had significantly lower end-infusion NIHSS (median 2 and range 0 to 16 for dramatic-recovery patients versus median 17 and range 6 to 35 for nondramatic-recovery patients, P<0.01) and 24-hour NIHSS (median 2 and range 0 to 16 for dramatic-recovery patients versus median 13 and range 2 to 35 for nondramatic-recovery patients, P<0.01). A long-term modified Rankin Score benefit was noted (median 1 and range 0 to 6 for dramatic-recovery patients versus median 4 and range 0 to 6 for nondramatic-recovery patients, P<0.01). Baseline clinical characteristics were similar. The only difference was improved TCD-determined flow values at the end of infusion (normal restoration of flow was 58% in dramatic-recovery patients versus 14% in nondramatic-recovery patients, P<0.01). A characteristic pattern of recovery of deficit was noted.
Conclusions Early dramatic recovery in acute MCA stroke patients treated with intravenous tPA is relatively frequent. The benefit of dramatic recovery is maintained at 24 hours and over the long term. TCD monitoring suggests that dramatic recovery is a result of early restoration of MCA flow during the tPA infusion. The consistent pattern of early clinical recovery may help explain the mechanisms by which thrombolysis improves outcome and could suggest targets for enhancing the therapeutic effect of intravenous tPA.
Key Words: recovery of function thrombolytic therapy ultrasonography
This article has been cited by other articles:
![]() |
R. Gasparotti, M. Grassi, D. Mardighian, M. Frigerio, M. Pavia, R. Liserre, M. Magoni, L. Mascaro, A. Padovani, and A. Pezzini Perfusion CT in Patients with Acute Ischemic Stroke Treated with Intra-Arterial Thrombolysis: Predictive Value of Infarct Core Size on Clinical Outcome AJNR Am. J. Neuroradiol., April 1, 2009; 30(4): 722 - 727. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Stolz, F. Cioli, J. Allendoerfer, T. Gerriets, M. Del Sette, and M. Kaps Can Early Neurosonology Predict Outcome in Acute Stroke?: A Metaanalysis of Prognostic Clinical Effect Sizes Related to the Vascular Status Stroke, December 1, 2008; 39(12): 3255 - 3261. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saqqur, G. Tsivgoulis, C. A. Molina, A. M. Demchuk, M. Siddiqui, J. Alvarez-Sabin, K. Uchino, S. Calleja, A. V. Alexandrov, and For the CLOTBUST Investigators Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: A multicenter study Neurology, October 21, 2008; 71(17): 1304 - 1312. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Smith, G. Sung, J. Saver, R. Budzik, G. Duckwiler, D. S. Liebeskind, H. L. Lutsep, M. M. Rymer, R. T. Higashida, S. Starkman, et al. Mechanical Thrombectomy for Acute Ischemic Stroke: Final Results of the Multi MERCI Trial Stroke, April 1, 2008; 39(4): 1205 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Seeck and S. Vulliemoz SEIZURES DURING STROKE THROMBOLYSIS HERALDING DRAMATIC NEUROLOGIC RECOVERY Neurology, July 24, 2007; 69(4): 409 - 410. [Full Text] [PDF] |
||||
![]() |
R. Mikulik, M. Ribo, M. D. Hill, J. C. Grotta, M. Malkoff, C. Molina, M. Rubiera, R. Delgado-Mederos, J. Alvarez-Sabin, A. V. Alexandrov, et al. Accuracy of Serial National Institutes of Health Stroke Scale Scores to Identify Artery Status in Acute Ischemic Stroke Circulation, May 22, 2007; 115(20): 2660 - 2665. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.S.V. Elkind, S. Prabhakaran, J. Pittman, W. Koroshetz, M. Jacoby, K. C. Johnston, and for the GAIN Americas Investigators Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke Neurology, March 13, 2007; 68(11): 842 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saqqur, C. A. Molina, A. Salam, M. Siddiqui, M. Ribo, K. Uchino, S. Calleja, Z. Garami, K. Khan, N. Akhtar, et al. Clinical Deterioration After Intravenous Recombinant Tissue Plasminogen Activator Treatment: A Multicenter Transcranial Doppler Study Stroke, January 1, 2007; 38(1): 69 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Legge, G. Saposnik, Y. Nilanont, and V. Hachinski Neglecting the Difference: Does Right or Left Matter in Stroke Outcome After Thrombolysis? Stroke, August 1, 2006; 37(8): 2066 - 2069. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Saposnik, S. Di Legge, F. Webster, and V. Hachinski Predictors of major neurologic improvement after thrombolysis in acute stroke Neurology, October 25, 2005; 65(8): 1169 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Savitz, G. Schlaug, L. Caplan, and M. Selim Arterial Occlusive Lesions Recanalize More Frequently in Women Than in Men After Intravenous Tissue Plasminogen Activator Administration for Acute Stroke Stroke, July 1, 2005; 36(7): 1447 - 1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ogata, T. Kitazono, J. Kuroda, K. Kamei, M. Kamouchi, H. Ooboshi, S. Ibayashi, and M. Iida A Case of Recanalized Cardioembolic Stroke: Possible Effect of Transcranial Color-Coded Real-time Sonography on Thrombolytic Therapy J. Ultrasound Med., April 1, 2005; 24(4): 561 - 565. [Full Text] [PDF] |
||||
![]() |
M. Saqqur, A. Shuaib, A. V. Alexandrov, M. D. Hill, S. Calleja, T. Tomsick, J. Broderick, and A. M. Demchuk Derivation of Transcranial Doppler Criteria for Rescue Intra-arterial Thrombolysis: Multicenter Experience From the Interventional Management of Stroke Study Stroke, April 1, 2005; 36(4): 865 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Alexandrov Ultrasound Identification and Lysis of Clots Stroke, November 1, 2004; 35(11_suppl_1): 2722 - 2725. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Saposnik, B. Young, B. Silver, S. Di Legge, F. Webster, V. Beletsky, V. Jain, Y. Nilanont, and V. Hachinski Lack of Improvement in Patients With Acute Stroke After Treatment With Thrombolytic Therapy: Predictors and Association With Outcome JAMA, October 20, 2004; 292(15): 1839 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Leigh, O. O. Zaidat, M. F. Suri, G. Lynch, S. Sundararajan, J. L. Sunshine, R. Tarr, W. Selman, D. M.D. Landis, and J. I. Suarez Predictors of Hyperacute Clinical Worsening in Ischemic Stroke Patients Receiving Thrombolytic Therapy Stroke, August 1, 2004; 35(8): 1903 - 1907. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Sloan, A. V. Alexandrov, C. H. Tegeler, M. P. Spencer, L. R. Caplan, E. Feldmann, L. R. Wechsler, D. W. Newell, C. R. Gomez, V. L. Babikian, et al. Assessment: Transcranial Doppler ultrasonography: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology, May 11, 2004; 62(9): 1468 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Saver, C. Kidwell, M. Eckstein, S. Starkman, and for the FAST-MAG Pilot Trial Investigators Prehospital Neuroprotective Therapy for Acute Stroke: Results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) Pilot Trial Stroke, May 1, 2004; 35(5): e106 - e108. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Straub, U. Junghans, V. Jovanovic, H. J. Wittsack, R. J. Seitz, and M. Siebler Systemic Thrombolysis With Recombinant Tissue Plasminogen Activator and Tirofiban in Acute Middle Cerebral Artery Occlusion Stroke, March 1, 2004; 35(3): 705 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Brown, K. C. Johnston, D. P. Wagner, and E. C. Haley Jr Predicting Major Neurological Improvement With Intravenous Recombinant Tissue Plasminogen Activator Treatment of Stroke Stroke, January 1, 2004; 35(1): 147 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Molina Editorial Comment--Degree of Arterial Recanalization: An End Point For Efficacy in Future Intravenous Thrombolytic Trials Stroke, January 1, 2004; 35(1): 114 - 115. [Full Text] [PDF] |
||||
![]() |
R. A. Felberg Editorial Comment--The MOST Score: Modifying the Open-Artery "Good"-Closed-Artery "Bad" Approach to Thrombolysis Prognosis Stroke, January 1, 2004; 35(1): 156 - 157. [Full Text] [PDF] |
||||
![]() |
C. A. Molina, A. V. Alexandrov, A. M. Demchuk, M. Saqqur, K. Uchino, and J. Alvarez-Sabin Improving the Predictive Accuracy of Recanalization on Stroke Outcome in Patients Treated With Tissue Plasminogen Activator Stroke, January 1, 2004; 35(1): 151 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Seitz, M. Hamzavi, U. Junghans, P. A. Ringleb, C. Schranz, and M. Siebler Thrombolysis With Recombinant Tissue Plasminogen Activator and Tirofiban in Stroke: Preliminary Observations Stroke, August 1, 2003; 34(8): 1932 - 1935. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |